Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
EDOXABAN
(2015)
Small molecule
Unknown
Unknown
Approved
Thrombosis
EDOXABAN
×
Maximum Phase:
4
First Approval:
2015
UNII:
NDU3J18APO
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClN7O4S
Molecular Weight:
548.07
AlogP:
1.29
PSA:
136.63
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TIPIRACIL HYDROCHLORIDE
(2015)
Small molecule
Thymidine phosphorylase inhibitor
Unknown
Approved
Colorectal Neoplasms
TIPIRACIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2015
UNII:
4H59KLQ0A4
Molecule Type:
Small molecule
Molecular Formula:
C9H12Cl2N4O2
Molecular Weight:
279.13
AlogP:
1.11
PSA:
93.33
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ISAVUCONAZONIUM SULFATE
(2015)
Small molecule
Lanosterol 14-alpha demethylase inhibitor
INTRAVENOUS; ORAL
Approved
Aspergillosis; Mucormycosis
ISAVUCONAZONIUM SULFATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
31Q44514JV
Molecule Type:
Small molecule
Molecular Formula:
C35H36F2N8O9S2
Molecular Weight:
814.85
AlogP:
4.58
PSA:
159.37
HBD:
2.0
HBA:
#RotB:
13.0
Source:
CARIPRAZINE
(2015)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
CARIPRAZINE
×
Maximum Phase:
4
First Approval:
2015
UNII:
F6RJL8B278
Molecule Type:
Small molecule
Molecular Formula:
C21H32Cl2N4O
Molecular Weight:
427.42
AlogP:
4.34
PSA:
38.82
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CHOLIC ACID
(2015)
Small molecule
Unknown
ORAL
Approved
Liver Diseases; Peroxisomal Disorders
CHOLIC ACID
×
Maximum Phase:
4
First Approval:
2015
UNII:
G1JO7801AE
Molecule Type:
Small molecule
Molecular Formula:
C24H40O5
Molecular Weight:
408.58
AlogP:
3.45
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
4.0
Source:
SELEXIPAG
(2015)
Small molecule
Prostanoid IP receptor agonist
ORAL
Approved
Familial Primary Pulmonary Hypertension; Pulmonary Arterial Hypertension; Thrombosis
SELEXIPAG
×
Maximum Phase:
4
First Approval:
2015
UNII:
5EXC0E384L
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O4S
Molecular Weight:
496.63
AlogP:
3.9
PSA:
101.49
HBD:
1.0
HBA:
#RotB:
12.0
Source:
OSIMERTINIB
(2015)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
OSIMERTINIB
×
Maximum Phase:
4
First Approval:
2015
UNII:
3C06JJ0Z2O
Molecule Type:
Small molecule
Molecular Formula:
C28H33N7O2
Molecular Weight:
499.62
AlogP:
4.51
PSA:
87.55
HBD:
2.0
HBA:
#RotB:
10.0
Source:
LUMACAFTOR
(2015)
Small molecule
Cystic fibrosis transmembrane conductance regulator stabiliser
Unknown
Approved
Cystic Fibrosis
LUMACAFTOR
×
Maximum Phase:
4
First Approval:
2015
UNII:
EGP8L81APK
Molecule Type:
Small molecule
Molecular Formula:
C24H18F2N2O5
Molecular Weight:
452.41
AlogP:
4.75
PSA:
97.75
HBD:
2.0
HBA:
#RotB:
5.0
Source:
LENVATINIB MESYLATE
(2015)
Small molecule
Vascular endothelial growth factor receptor inhibitor
ORAL
Approved
Carcinoma, Renal Cell; Thyroid Neoplasms
LENVATINIB MESYLATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
3J78384F61
Molecule Type:
Small molecule
Molecular Formula:
C22H23ClN4O7S
Molecular Weight:
522.97
AlogP:
4.07
PSA:
115.57
HBD:
3.0
HBA:
#RotB:
6.0
Source:
HELIUM
(2015)
Small molecule
Unknown
INHALATION
Approved
Unknown
HELIUM
×
Maximum Phase:
4
First Approval:
2015
UNII:
206GF3GB41
Molecule Type:
Small molecule
Molecular Formula:
He
Molecular Weight:
4.0
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LENVATINIB
(2015)
Small molecule
Unknown
Unknown
Approved
Neoplasms; Thyroid Neoplasms
LENVATINIB
×
Maximum Phase:
4
First Approval:
2015
UNII:
EE083865G2
Molecule Type:
Small molecule
Molecular Formula:
C21H19ClN4O4
Molecular Weight:
426.86
AlogP:
4.07
PSA:
115.57
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PALBOCICLIB
(2015)
Small molecule
CDK6/cyclin D1 inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
PALBOCICLIB
×
Maximum Phase:
4
First Approval:
2015
UNII:
G9ZF61LE7G
Molecule Type:
Small molecule
Molecular Formula:
C24H29N7O2
Molecular Weight:
447.54
AlogP:
2.97
PSA:
105.04
HBD:
2.0
HBA:
#RotB:
5.0
Source:
AVIBACTAM SODIUM
(2015)
Small molecule
Bacterial beta-lactamase TEM inhibitor
Unknown
Approved
Intraabdominal Infections; Pyelonephritis; Urinary Tract Infections
AVIBACTAM SODIUM
×
Maximum Phase:
4
First Approval:
2015
UNII:
9V824P8TAI
Molecule Type:
Small molecule
Molecular Formula:
C7H10N3NaO6S
Molecular Weight:
287.23
AlogP:
-1.53
PSA:
130.24
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ISAVUCONAZONIUM
(2015)
Small molecule
Unknown
Unknown
Approved
Unknown
ISAVUCONAZONIUM
×
Maximum Phase:
4
First Approval:
2015
UNII:
VH2L779W8Q
Molecule Type:
Small molecule
Molecular Formula:
C35H35F2N8O5S+
Molecular Weight:
717.78
AlogP:
4.58
PSA:
159.37
HBD:
2.0
HBA:
#RotB:
13.0
Source:
DACLATASVIR
(2015)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
DACLATASVIR
×
Maximum Phase:
4
First Approval:
2015
UNII:
LI2427F9CI
Molecule Type:
Small molecule
Molecular Formula:
C40H50N8O6
Molecular Weight:
738.89
AlogP:
6.22
PSA:
174.64
HBD:
4.0
HBA:
#RotB:
11.0
Source:
TRABECTEDIN
(2015)
Small molecule
DNA inhibitor
INTRAVENOUS
Approved
Leiomyosarcoma; Liposarcoma; Neoplasms
TRABECTEDIN
×
Maximum Phase:
4
First Approval:
2015
UNII:
ID0YZQ2TCP
Molecule Type:
Small molecule
Molecular Formula:
C39H43N3O11S
Molecular Weight:
761.85
AlogP:
3.41
PSA:
168.72
HBD:
4.0
HBA:
#RotB:
3.0
Source:
PERINDOPRIL ARGININE
(2015)
Small molecule
Angiotensin-converting enzyme inhibitor
Unknown
Approved
Coronary Artery Disease; Hypertension; Myocardial Infarction
PERINDOPRIL ARGININE
×
Maximum Phase:
4
First Approval:
2015
UNII:
TFT5IM1KGB
Molecule Type:
Small molecule
Molecular Formula:
C25H46N6O7
Molecular Weight:
542.68
AlogP:
1.94
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IXAZOMIB CITRATE
(2015)
Small molecule
26S proteosome inhibitor
ORAL
Approved
Multiple Myeloma; Neoplasms
IXAZOMIB CITRATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
46CWK97Z3K
Molecule Type:
Small molecule
Molecular Formula:
C20H23BCl2N2O9
Molecular Weight:
517.13
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TIPIRACIL
(2015)
Small molecule
Unknown
Unknown
Approved
Unknown
TIPIRACIL
×
Maximum Phase:
4
First Approval:
2015
UNII:
NGO10K751P
Molecule Type:
Small molecule
Molecular Formula:
C9H11ClN4O2
Molecular Weight:
242.67
AlogP:
1.11
PSA:
93.33
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ROLAPITANT HYDROCHLORIDE
(2015)
Small molecule
Neurokinin 1 receptor antagonist
INTRAVENOUS; ORAL
Approved
Nausea; Postoperative Nausea and Vomiting
ROLAPITANT HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2015
UNII:
57O5S1QSAQ
Molecule Type:
Small molecule
Molecular Formula:
C25H29ClF6N2O3
Molecular Weight:
554.96
AlogP:
5.73
PSA:
50.36
HBD:
2.0
HBA:
#RotB:
5.0
Source:
IVABRADINE HYDROCHLORIDE
(2015)
Small molecule
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker
ORAL
Approved
Heart Failure
IVABRADINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2015
UNII:
TP19837BZK
Molecule Type:
Small molecule
Molecular Formula:
C27H37ClN2O5
Molecular Weight:
505.06
AlogP:
3.31
PSA:
60.47
HBD:
0.0
HBA:
#RotB:
10.0
Source:
CANGRELOR TETRASODIUM
(2015)
Small molecule
Purinergic receptor P2Y12 antagonist
Unknown
Approved
Myocardial Infarction; Thrombosis
CANGRELOR TETRASODIUM
×
Maximum Phase:
4
First Approval:
2015
UNII:
2144G00Y7W
Molecule Type:
Small molecule
Molecular Formula:
C17H21Cl2F3N5Na4O12P3S2
Molecular Weight:
864.29
AlogP:
2.85
PSA:
255.91
HBD:
7.0
HBA:
#RotB:
15.0
Source:
FERRIC PYROPHOSPHATE CITRATE
(2015)
Small molecule
Supplement
INTRAVENOUS
Approved
Unknown
FERRIC PYROPHOSPHATE CITRATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
UBY79OCO9G
Molecule Type:
Small molecule
Molecular Formula:
C18H24Fe4O42P6
Molecular Weight:
1321.57
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BREXPIPRAZOLE
(2015)
Small molecule
Dopamine D2 receptor partial agonist
ORAL
Approved
Depressive Disorder, Major; Psychotic Disorders; Schizophrenia
BREXPIPRAZOLE
×
Maximum Phase:
4
First Approval:
2015
UNII:
2J3YBM1K8C
Molecule Type:
Small molecule
Molecular Formula:
C25H27N3O2S
Molecular Weight:
433.58
AlogP:
4.72
PSA:
48.57
HBD:
1.0
HBA:
#RotB:
7.0
Source:
DEOXYCHOLIC ACID
(2015)
Small molecule
Cell membrane disrupting agent
SUBCUTANEOUS
Approved
Unknown
DEOXYCHOLIC ACID
×
Maximum Phase:
4
First Approval:
2015
UNII:
005990WHZZ
Molecule Type:
Small molecule
Molecular Formula:
C24H40O4
Molecular Weight:
392.58
AlogP:
4.48
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
4.0
Source:
NITROGEN
(2015)
Small molecule
Unknown
INHALATION
Approved
Unknown
NITROGEN
×
Maximum Phase:
4
First Approval:
2015
UNII:
N762921K75
Molecule Type:
Small molecule
Molecular Formula:
N2
Molecular Weight:
28.01
AlogP:
0.03
PSA:
47.58
HBD:
0.0
HBA:
#RotB:
0.0
Source:
GRAZOPREVIR
(2016)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Approved
Hepatitis C, Chronic; Virus Diseases
GRAZOPREVIR
×
Maximum Phase:
3
First Approval:
2016
UNII:
4O2AB118LA
Molecule Type:
Small molecule
Molecular Formula:
C38H52N6O10S
Molecular Weight:
784.93
AlogP:
3.3
PSA:
195.22
HBD:
3.0
HBA:
#RotB:
7.0
Source:
PIMAVANSERIN TARTRATE
(2016)
Small molecule
Serotonin 2a (5-HT2a) receptor inverse agonist
ORAL
Approved
Hallucinations; Parkinson Disease; Psychotic Disorders
PIMAVANSERIN TARTRATE
×
Maximum Phase:
4
First Approval:
2016
UNII:
NA83F1SJSR
Molecule Type:
Small molecule
Molecular Formula:
C54H74F2N6O10
Molecular Weight:
1005.21
AlogP:
4.67
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BRIVARACETAM
(2016)
Small molecule
Synaptic vesicle glycoprotein 2A modulator
INTRAVENOUS; ORAL
Approved
Epilepsy; Seizures
BRIVARACETAM
×
Maximum Phase:
4
First Approval:
2016
UNII:
U863JGG2IA
Molecule Type:
Small molecule
Molecular Formula:
C11H20N2O2
Molecular Weight:
212.29
AlogP:
0.9
PSA:
63.4
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FLUCICLOVINE
(2016)
Small molecule
Unknown
Unknown
Approved
Unknown
FLUCICLOVINE
×
Maximum Phase:
4
First Approval:
2016
UNII:
YKG0YF688X
Molecule Type:
Small molecule
Molecular Formula:
C6H10FNO2
Molecular Weight:
147.15
AlogP:
0.29
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
RUCAPARIB CAMSYLATE
(2016)
Small molecule
PARP 1, 2 and 3 inhibitor
ORAL
Approved
Ovarian Neoplasms
RUCAPARIB CAMSYLATE
×
Maximum Phase:
4
First Approval:
2016
UNII:
41AX9SJ8KO
Molecule Type:
Small molecule
Molecular Formula:
C29H34FN3O5S
Molecular Weight:
555.67
AlogP:
2.98
PSA:
56.92
HBD:
3.0
HBA:
#RotB:
3.0
Source:
VELPATASVIR
(2016)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Approved
Hepatitis C, Chronic
VELPATASVIR
×
Maximum Phase:
4
First Approval:
2016
UNII:
KCU0C7RS7Z
Molecule Type:
Small molecule
Molecular Formula:
C49H54N8O8
Molecular Weight:
883.02
AlogP:
7.73
PSA:
193.1
HBD:
4.0
HBA:
#RotB:
11.0
Source:
BARIUM SULFATE
(2016)
Small molecule
Diagnostic agent
ORAL
Approved
Unknown
BARIUM SULFATE
×
Maximum Phase:
4
First Approval:
2016
UNII:
25BB7EKE2E
Molecule Type:
Small molecule
Molecular Formula:
BaO4S
Molecular Weight:
233.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VENETOCLAX
(2016)
Small molecule
Apoptosis regulator Bcl-2 inhibitor
ORAL
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms
VENETOCLAX
×
Maximum Phase:
4
First Approval:
2016
UNII:
N54AIC43PW
Molecule Type:
Small molecule
Molecular Formula:
C45H50ClN7O7S
Molecular Weight:
868.46
AlogP:
8.66
PSA:
172.03
HBD:
3.0
HBA:
#RotB:
13.0
Source:
ELBASVIR
(2016)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Approved
Hepatitis C, Chronic; Virus Diseases
ELBASVIR
×
Maximum Phase:
4
First Approval:
2016
UNII:
632L571YDK
Molecule Type:
Small molecule
Molecular Formula:
C49H55N9O7
Molecular Weight:
882.03
AlogP:
8.12
PSA:
188.8
HBD:
4.0
HBA:
#RotB:
11.0
Source:
EPHEDRINE
(2016)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases; Nasal Obstruction; Obesity
EPHEDRINE
×
Maximum Phase:
4
First Approval:
2016
UNII:
GN83C131XS
Molecule Type:
Small molecule
Molecular Formula:
C10H15NO
Molecular Weight:
165.24
AlogP:
1.33
PSA:
32.26
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
65
66
67
68
69
70
71
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA